Endeavour Silver Announces At-the-Market Offering of Up to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Endeavour Silver Announces At-the-Market Offering of Up to US $16.5 Million

VANCOUVER, BC--(Marketwired - November 25, 2015) - Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR) (the "Company" or "Endeavour") is pleased to announce it has entered into a sales agreement dated November 25, 2015 (the "Sales Agreement") with Cowen and Company, LLC ("Cowen"), pursuant to which the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through Cowen, as agent or principal, such number of common shares of the Company ("Common Shares") as would result in aggregate gross proceeds to the Company of up to US $16.5 million (the "Offering"). Sales of Common Shares will be made through "at the market distributions" as defined in National Instrument 44-102, including sales made directly on the New York Stock Exchange (the "NYSE"), or any other recognized marketplace upon which the Common Shares are listed or quoted or where the Common Shares are traded in the United States. The Common Shares will be distributed at the market prices prevailing at the time of each sale, and, as a result, prices may vary as between purchasers and during the period of distribution. No offers or sales of Common Shares will be made in Canada on the Toronto Stock Exchange (the "TSX") or other trading markets in Canada.

The Offering will be made by way of a prospectus supplement dated November 25, 2015, to the Company's existing U.S. registration statement on Form F-10 (the "Registration Statement") and Canadian short form base shelf prospectus (the "Base Shelf Prospectus"), each dated July 29, 2014. The prospectus supplement relating to the Offering has been filed with the securities commissions in each of the provinces of Canada (other than Québec) and the United States Securities and Exchange Commission. The U.S. prospectus supplement (together with the related Registration Statement) is available on the SEC's website (www.sec.gov) and the Canadian prospectus supplement (together with the related Base Shelf Prospectus) is available on the SEDAR website maintained by the Canadian Securities Administrators at www.sedar.com. Alternatively, Cowen will provide copies of the U.S. prospectus upon request by contacting Cowen and Company, LLC (c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, Phone: 631-274-2806, Fax: 631-254-7140).

The Company intends to use the net proceeds of the Offering, if any, together with the Company's current cash resources, to expedite the Company's brownfields exploration drilling programs at existing operations in order to extend their mine lives, to advance the exploration and development of the Company's Terronera Project with further drilling, engineering and related studies, and to add to working capital.

The Company will pay Cowen compensation, or allow a discount, equal to 3% of the gross sales price per Common Share sold under the Sales Agreement.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Endeavour - Endeavour Silver is a mid-tier silver mining company focused on growing production, reserves and resources in Mexico. Since start-up in 2004, Endeavour has posted ten consecutive years of accretive growth of its silver mining operations. Endeavour's three silver-gold mines in Mexico combined with its strategic acquisition and exploration programs should facilitate Endeavour's goal to become a premier senior silver producer.

Cautionary Note Regarding Forward-Looking Statements

Some of the statements contained in this release are forward-looking statements within the meaning of the United States Securities Act of 1933, as amended, and the United States Securities Exchange Act of 1934, as amended, and forward-looking information within the meaning of Canadian securities laws, such as statements that describe the anticipated offering of securities, the anticipated use of proceeds from any offering, and other statements. Since forward-looking statements are not statements of historical fact and address future events, conditions and expectations, forward-looking statements by their nature inherently involve unknown risks, uncertainties, assumptions and other factors well beyond the Company's ability to control or predict. Actual events, results and developments may differ materially from those contemplated by such forward-looking statements. Material factors that could cause actual events to differ materially from those described in such forwarding-looking statements include risks related to the Company's condition requiring anticipated use of proceeds to change, timing of, and ability to obtain, required regulatory approvals, and general economic and regulatory changes. These forward-looking statements represent the Company's views as of the date of this release. There can be no assurance that forward-looking statements will prove to be accurate, as actual events and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on any forward-looking statements.

Contact Information - For more information, please contact: Meghan Brown Director Investor Relations Toll free: 1-877-685-9775 Tel: 604-640-4804 Fax: 604-685-9744 Email: mbrown@edrsilver.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading

Top 5 Most Recently Viewed Articles

Impending Price Increases on Medications in the U.S. Market

Updated Category News Views 263

Upcoming Price Increases on Medications in the U.S. By Michael Erman Drugmakers are set to increase the prices of over 250 branded medications, including well-known treatments like Pfizer's COVID-19 drug Paxlovid and Bristol Myers Squibb's cancer therapies. According to an analysis from a healthcare research firm, these increases will take effect on January 1, 2025....

Continue Reading
The Joint Commission Welcomes New Digital Leadership to Advance Healthcare

Updated Category News Views 152

The Joint Commission Appoints William Walders as CDIO The Joint Commission recently unveiled an exciting new chapter in its leadership with the appointment of William Walders as vice president and chief digital and information officer (CDIO). This strategic decision marks a significant shift towards amplifying the organization's digital transformation efforts. Walders'...

Continue Reading
Understanding Market Sentiment for Green Brick Partners

Updated Category News Views 105

Market Overview for Green Brick Partners Green Brick Partners (NYSE: GRBK) is experiencing a notable uptick in its short interest, which has risen by 7.98% since the last report. Currently, there are approximately 1.24 million shares sold short, representing about 4.06% of the total shares available for trading. With the current trading volume, analysts estimate that it...

Continue Reading
Earnings Forecasts for Major Companies on October 22, 2025

Updated Category News Views 600

Upcoming Earnings Reports Many prominent companies are slated to disclose their quarterly earnings on October 22, 2025. Investors and analysts alike are keenly awaiting these reports to gauge the companies' performances and future outlooks. Before The Market Opens • Barclays (NYSE: BCS) is expected to announce earnings of $0.54 per share with projected revenue around...

Continue Reading
First Atlantic Nickel Amplifies Drilling Efforts at Pipestone XL

Updated Category News Views 176

First Atlantic Nickel Amplifies Drilling Efforts First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) is making significant strides in its mining efforts. The Company has announced the addition of four new drill holes (AN-25-11 to AN-25-14) to its Phase 2X drilling program, particularly within the RPM Zone of the Pipestone XL Nickel Alloy Project. This...

Continue Reading